newsfilter
← Latest News
GlobeNewswire·

Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development

Dr. Blackman's departure planned for end of 2024 Company's search for a new Head of R&D is ongoing BRISBANE, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) ("Day